New function released today – Modelling of variable dose regimen.
We are pleased to announce some added features to WAPPS-Hemo with the latest update.
WAPPS Team
August 20, 2020
WAPPS News
What’s New in version 5.2 WAPPS-Hemo
Version 5.2 of WAPPS-Hemo introduces a large set of minor incremental updates, many on the back-end, to make our human validation more efficient, many in the connectivity to external software and applications, and many to the look and general functionalities.
WAPPS Team
July 22, 2020
Launch of McMaster PopPK, a new CE-marked PK tool
For WAPPS-Hemo users located in Europe, McMaster is excited to announce the launch of McMaster PopPK. If you see value in using a CE-marked platform, then McMaster PopPK is now available for you. This new CE-marked platform provides individual pharmacokinetic parameters based on the trusted WAPPS-Hemo engine. McMaster PopPK is CE-marked as an in vitro diagnostic device class I in accordance with the EU IVD Directive. McMaster PopPK supports myWAPPS and florioTM to display estimated factor levels via patient smartphone apps.
WAPPS Team
July 13, 2020
WAPPS Team
June 22, 2020
WAPPS-Hemo is pleased to announce the launch of two new population pharmacokinetic (PK) models for ESPEROCT
WAPPS-Hemo is pleased to announce the launch of two new population pharmacokinetic (PK) models for ESPEROCT® (Antihemophilic Factor VIII (Recombinant, B-Domain Truncated), PEGylated) that use the one-stage and chromogenic assays.
WAPPS Team
June 11, 2020
Clinical Trials for WAPPS
Looking for an opportunity to participate in a clinical trial for WAPPS? There are currently two trials that are recruiting.
WAPPS Team
April 17, 2020
At WAPPS-News we post the latest updates and changes to the WAPPS-Hemo program. Check back with us regularly. Contact us if you have any questions.
The WAPPS-HEMO Team
